Richard J. Cassidy III, MD, on NSCLC and SBRT in Older Patients

2017 Multidisciplinary Thoracic Cancers Symposium
Tweet this page

Richard J. Cassidy III, MD, of Emory Winship Cancer Institute, discusses results from a multicenter analysis of stereotactic body radiotherapy for early-stage non-small cell lung cancer in patients 80 years and older; the patients tolerated the treatment well and had excellent estimated rates of 5-year cancer-specific survival (Abstract 111).